New hope for advanced prostate cancer patients, with promising new drug combo that targets genes, such as BRCA1, BRCA2, CHEK2 ...

Mutations in the BRCA1 gene that are either inherited (germline) or acquired (somatic) might not be key to the initiation of prostate cancer, as previously thought, suggests the first study of its ...

People inherit two copies of each gene — one from each parent — an evolutionary fail-safe to ensure survival even when one of them doesn’t function. Likely not, according to the findings of a new ...

A study led by Harvard Medical School researchers shed new light on how even a single defective copy of the tumor-suppressor BRCA1 gene can increase patients’ risk of developing breast cancer.

With breast cancer on both sides of the family, a 29-year-old Utah attorney opted to reduce her own risk drastically.

September 29, 2008 — Hormone therapy does not appear to elevate the risk for breast cancer in postmenopausal women with a BRCA1 mutation, researchers report. In fact, according to the study published ...

In 'Ofrenda,' an ultrarunner confronts a medical diagnosis — and her mother's death — by setting a fastest known time on one ...

Men with BRCA1 and BRCA2 gene mutations should be given annual prostate cancer screening checks, leading scientists have said ...

In women with BRCA1 mutations, hormonal contraceptives were associated with a significantly higher risk for breast cancer in a dose-response relationship, researchers reported in an observational ...

Women with BRCA1/2 mutations are faced with complex decisions about breast and ovarian cancer risk management. This study was conducted to determine the effect of a tailored decision support system ...

Genetic testing for BRCA1 mutations offers individuals the opportunity to make informed health decisions and take control of their future. The concept of being a "previvor" involves navigating the ...